Bridger Management as of June 30, 2022
Portfolio Holdings for Bridger Management
Bridger Management holds 43 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Charter Communications Inc N Cl A (CHTR) | 7.2 | $32M | 68k | 468.54 | |
Godaddy Cl A (GDDY) | 7.0 | $31M | 446k | 69.56 | |
Centene Corporation (CNC) | 6.1 | $27M | 318k | 84.61 | |
Morgan Stanley Com New (MS) | 5.9 | $26M | 342k | 76.06 | |
Astrazeneca Sponsored Adr (AZN) | 5.6 | $25M | 377k | 66.07 | |
Clarivate Ord Shs (CLVT) | 5.1 | $23M | 1.6M | 13.86 | |
Alcon Ord Shs (ALC) | 4.9 | $22M | 313k | 69.89 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 4.6 | $21M | 73k | 281.79 | |
Uber Technologies (UBER) | 4.6 | $20M | 993k | 20.46 | |
BioMarin Pharmaceutical (BMRN) | 3.9 | $17M | 208k | 82.87 | |
Humana (HUM) | 3.7 | $16M | 35k | 468.06 | |
Caesars Entertainment (CZR) | 3.6 | $16M | 412k | 38.30 | |
Verisign (VRSN) | 3.5 | $16M | 94k | 167.33 | |
The Beauty Health Company Com Cl A (SKIN) | 3.2 | $14M | 1.1M | 12.86 | |
Irhythm Technologies (IRTC) | 2.9 | $13M | 120k | 108.03 | |
Post Holdings Partnering Cor Unit 99/99/9999 | 2.8 | $12M | 1.3M | 9.77 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 2.5 | $11M | 1.5M | 7.52 | |
Ironwood Pharmaceuticals Com Cl A (IRWD) | 2.5 | $11M | 956k | 11.53 | |
Avanti Acquisition Corp Unit 99/99/9999 | 2.3 | $10M | 1.0M | 10.00 | |
Airsculpt Technologies (AIRS) | 2.2 | $9.7M | 1.6M | 5.93 | |
Williams Rowland Acquisition | 2.1 | $9.5M | 950k | 10.00 | |
Insulet Corporation (PODD) | 2.0 | $8.9M | 41k | 217.95 | |
Post Holdings Inc Common (POST) | 1.9 | $8.3M | 100k | 82.35 | |
Flame Acquisition Corp Com Cl A | 1.1 | $4.9M | 500k | 9.79 | |
Rxsight (RXST) | 1.1 | $4.7M | 331k | 14.08 | |
Bellring Brands Common Stock (BRBR) | 1.0 | $4.7M | 187k | 24.89 | |
Docebo (DCBO) | 1.0 | $4.3M | 150k | 28.67 | |
R1 RCM (RCM) | 0.9 | $3.9M | 186k | 20.96 | |
Livanova SHS (LIVN) | 0.8 | $3.5M | 56k | 62.46 | |
Xenon Pharmaceuticals (XENE) | 0.5 | $2.4M | 77k | 30.43 | |
Quanterix Ord (QTRX) | 0.5 | $2.3M | 145k | 16.19 | |
Advisorshares Tr Pure Us Cannabis (MSOS) | 0.5 | $2.2M | 214k | 10.35 | |
Surrozen Cl A | 0.5 | $2.1M | 700k | 3.00 | |
Abcam Ads | 0.5 | $2.1M | 142k | 14.46 | |
Dermtech Ord ord (DMTKQ) | 0.4 | $1.9M | 351k | 5.54 | |
Privia Health Group (PRVA) | 0.3 | $1.3M | 44k | 29.12 | |
ImmunoGen | 0.3 | $1.3M | 278k | 4.50 | |
Nautilus Biotechnology (NAUT) | 0.2 | $777k | 289k | 2.69 | |
Miragen Therapeutics (VRDN) | 0.2 | $767k | 66k | 11.57 | |
Neximmune | 0.1 | $644k | 400k | 1.61 | |
Bio-techne Corporation (TECH) | 0.1 | $501k | 1.4k | 346.95 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $89k | 467k | 0.19 | |
Williams Rowland Acquisition *w Exp 12/11/202 | 0.0 | $40k | 475k | 0.08 |